JPMorgan Chase & Co. trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 10.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,850,243 shares of the medical research company’s stock after selling 1,295,367 shares during the quarter. JPMorgan Chase & Co. owned approximately 3.37% of Agilent Technologies worth $694,199,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Virginia Retirement Systems ET AL increased its position in Agilent Technologies by 45.6% in the third quarter. Virginia Retirement Systems ET AL now owns 51,400 shares of the medical research company’s stock worth $3,300,000 after purchasing an additional 16,100 shares during the period. Legal & General Group Plc increased its position in Agilent Technologies by 2.9% in the third quarter. Legal & General Group Plc now owns 1,690,240 shares of the medical research company’s stock worth $108,512,000 after purchasing an additional 46,962 shares during the period. Great West Life Assurance Co. Can increased its position in Agilent Technologies by 1.8% in the third quarter. Great West Life Assurance Co. Can now owns 233,664 shares of the medical research company’s stock worth $14,934,000 after purchasing an additional 4,066 shares during the period. Nordea Investment Management AB increased its position in Agilent Technologies by 4.9% in the third quarter. Nordea Investment Management AB now owns 16,484 shares of the medical research company’s stock worth $1,058,000 after purchasing an additional 774 shares during the period. Finally, Robecosam AG increased its position in Agilent Technologies by 16.0% in the third quarter. Robecosam AG now owns 614,706 shares of the medical research company’s stock worth $39,329,000 after purchasing an additional 84,862 shares during the period.

Several equities analysts have recently issued reports on the company. BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 12th. Cowen Inc restated a “hold” rating and set a $70.00 target price on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Janney Montgomery Scott boosted their target price on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, August 16th. Robert W. Baird restated a “buy” rating and set a $72.00 target price on shares of Agilent Technologies in a research report on Friday. Finally, J P Morgan Chase & Co restated an “overweight” rating and set a $70.00 target price on shares of Agilent Technologies in a research report on Wednesday, August 16th. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $68.34.

Agilent Technologies, Inc. (A) opened at $69.36 on Monday. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $70.81. The company has a current ratio of 3.30, a quick ratio of 2.76 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $22,320.00, a PE ratio of 28.98, a PEG ratio of 2.07 and a beta of 1.28.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The business had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter in the previous year, the business posted $0.59 EPS. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. analysts forecast that Agilent Technologies, Inc. will post 2.58 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be issued a dividend of $0.149 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s payout ratio is 25.24%.

In other Agilent Technologies news, insider Patrick Kaltenbach sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.26, for a total value of $326,300.00. Following the sale, the insider now owns 45,143 shares in the company, valued at approximately $2,946,032.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Didier Hirsch sold 1,200 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $66.00, for a total value of $79,200.00. Following the completion of the sale, the chief financial officer now owns 164,202 shares in the company, valued at approximately $10,837,332. The disclosure for this sale can be found here. Insiders have sold a total of 107,709 shares of company stock worth $7,195,576 in the last quarter.

COPYRIGHT VIOLATION WARNING: This article was posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.watchlistnews.com/jpmorgan-chase-co-lowers-position-in-agilent-technologies-inc-a/1728681.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.